Last reviewed · How we verify
NCT05967780
Comparison of Open Heart Surgery Patients With Forward Head Posture With and Without Perioperative Therapeutic Exercise
NA trial testing Group A: Patients with FHP receiving standard cardiac rehabilitation in Cardiac Rehabilitation in 48 participants. Completed in 31 December 2023.
31 December 2023
Quick facts
| Lead sponsor | Health Education Research Foundation (HERF) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 17 August 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Group A: Patients with FHP receiving standard cardiac rehabilitation
- Group B: Patients with FHP receiving standard cardiac rehabilitation + therapeutic exercises
- Group C: Patients without FHP receiving standard cardiac rehabilitation
Conditions studied
- Cardiac Rehabilitation — all drugs for Cardiac Rehabilitation →
Sponsor
Health Education Research Foundation (HERF)
Who can join
Adults 30 to 60, male only, with Cardiac Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison of open heart surgery patients with forward head posture with and without perioperative therapeutic exercise on craniovertebral angle, pulmonary function, balance and quality of life
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05967780
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Rehabilitation
Currently open trials in the same condition.
- NCT07500077 — Strength and Balance Integration in Maintenance Cardiac Rehabilitation for Older Adults · NA · recruiting
- NCT07164911 — Predictive Factors of Response to Phase II Cardiac Rehabilitation in Heart Failure With Reduced Ejection Fraction · recruiting
- NCT07096973 — Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery · recruiting
- NCT07123480 — The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance · NA · active not recruiting
- NCT07094737 — The Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P) Registry: An Observational Study on Ca · recruiting
Other Health Education Research Foundation (HERF) trials
Trials by the same sponsor.
- NCT06101368 — Effect of Physical Activity on Neurogenesis in Peripheral Diabetic Neuropathy Type-II Diabetes · NA · unknown
- NCT06081023 — Development and Feasibility of Psycho-Educational Weight Reduction Program for Young Adults · NA · completed
- NCT05189626 — Effectiveness of Kaltenborn Mobilizations Versus Muscle Energy Technique in Adhesive Capsulitis. · NA · unknown
- NCT05870904 — Dry Needling & Trigger Point Compression Release in Neck Pain · NA · completed
- NCT05849545 — Effects of Garston Tool and Neuromuscular Reeducation in Cervical Headache · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05967780 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Health Education Research Foundation (HERF)
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05967780.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing